Abstract:Background: Mucorales infections continue to cause significant morbidity and mortality in immunocompromised hosts despite the advent of new approaches for diagnosis and treatment of fungal infections. We aimed to evaluate risk factors and outcomes of Mucorales infection in solid organ transplant, hematopoietic cell transplant, and chimeric antigen receptor T-cell therapy recipients. Methods: This single-center retrospective study included solid organ transplant, hematopoietic cell transplant, and chimeric antigen receptor T-cell patients with cultures positive for Mucorales. Results: Forty-three patients were included for analysis; 34 solid organ transplant (79%) and 9 hematopoietic stem cell transplant or chimeric antigen receptor T-cell (21%). Infection with Mucorales occurred a median of 184 days after transplant. At the time of diagnosis, 36 patients were on antifungal prophylaxis with the majority receiving posaconazole (53%). Thirty-three had clinically significant disease; 30 received definitive anti-Mucorales therapy and 3 empiric antifungal therapy. Isavuconazole was the most common azole used for treatment in monotherapy recipients. All-cause mortality was 64% and, of these deaths, 18 (75%) were directly related to Mucormycosis. The highest mortality was seen in disseminated and intra-abdominal disease (100%), followed by pulmonary disease (50%). There was no significant association with mortality and transplant type or number of immunosuppressive agents. Conclusion: Mucormycosis is an important cause of morbidity and mortality in immunocompromised patients. Breakthrough infection was not uncommon in this study. Data regarding the incidence of infection at approximately 6 months after transplantation can inform prophylaxis and treatment regimens. The spectrum of antifungal regimens used reflects the lack of consensus on ideal regimens for these organisms and a need for more studies.

Successful management of wound mucormycosis in a combined hepatic and renal transplant recipient: A case report and literature review

Mucormycosis in Renal Transplant Recipients: Review of 174 Reported Cases.

The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review

Fatal Gastrointestinal Mucormycosis in an Immunocompetent Patient : a Case Report and Review of the Literature

Cerebral mucormycosis after liver transplantation: a case report

[Clinical High Risk Factors and Prognosis of 25 Pulmonary Mucormycosis Cases].

Successful Treatment of a Necrotizing Fasciitis Patient Caused by Mucor Indicus with Amphotericin B and Skin Grafting

Epidemiology, clinical manifestations, and outcome of mucormycosis in solid organ transplant recipients: a systematic review of reported cases

One case of gastrointestinal mucor infection secondary to severe pneumonia after renal transplantation and literature review

Fatal Mucormycosis in a Diabetic Patient: A Case Report and Review of Diagnostic Challenges

Oral Isavuconazole Combined with Nebulized Inhalation and Bronchoscopic Administration of Amphotericin B for the Treatment of Pulmonary Mucormycosis: A Case Report and Literature Review

Successful Management of Angioinvasive Deep Fungal Infections of the Penis: A Multidisciplinary Approach with Intraoperative Frozen Margins

Risk Factors and Outcomes of Mucorales Infection in a Modern Cohort of Solid Organ Transplant, Hematopoietic Cell Transplant, and Chimeric Antigen Receptor T-cell Therapy Recipients

Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature

Disseminated Talaromyces marneffei infection after renal transplantation: A case report and literature review

Invasive, gangrenous mucormycosis of arm: A fatal opportunistic infection in a highly immunocompromised host

Proven Cutaneous Mucormycosis in a COVID-19 Patient: A Case Report and Literature Review

Diagnosis and Treatments of Mucor Infection after Allogenic Organ Transplantation

Surgical treatment of appendiceal mucormycosis in an immunocompromised patient: a case report

Deep cutaneous mycoses in kidney transplant recipients: Diagnostic and therapeutic challenges

Mucormycosis treatment: Recommendations, latest advances, and perspectives